Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris
Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris
Congressman Earl Blumenauer, a Democrat from Oregon and co-chair of the Congressional Cannabis Caucus says he's disappointed the U.S. Drug Enforcement Administration (DEA) chose to delay rescheduling of marijuana.
俄勒岡州的民主黨議員厄爾·布盧門納表示，他對美國緝毒局（DEA）推遲將大麻重新分類的決定感到失望。
"It is incredibly disappointing to see the DEA drag their feet on an issue which has been a clear White House priority," the top Democrat said on Tuesday.
這位民主黨最高領導人在週二表示：「在這個白宮已明確優先考慮的問題上，看到緝毒局拖拖拉拉是令人非常失望的。」
The move would likely result in pushing any decision on the matter until after the 2024 election.
這一舉動很可能會導致在2024年選舉之後再決定這個問題。
Yet, Blumenauer remains optimistic.
然而，布盧門納仍然持樂觀態度。
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
- 獲取Benzinga獨家分析以及關於大麻行業和市場的最新資訊，每天免費發送到您的郵箱。點擊此處訂閱我們的新聞稿。如果您認真對待業務，那麼不能錯過。
"While I would have preferred to see rescheduling finalized before the election, we still have every reason to believe that it will happen before President Biden leaves office," he said. "I also have every hope that because of our work together, soon-to-be President Harris will take further steps to rationalize cannabis policy and end the failed war on drugs."
他說：「雖然我希望在選舉之前能夠完成重新分類，但我們仍然有充分的理由相信，它將在拜登總統離任之前發生。我也相信，由於我們的共同努力，即將成爲總統的賀錦麗將採取進一步的措施來合理化大麻政策並結束失敗的禁毒戰爭。」
Read Also: Kamala Harris, Tim Walz Form First Explicitly Pro-Cannabis Legalization Presidential Ticket In History
閱讀更多：賀錦麗和蒂姆·沃爾茲歷史上首個明確倡導大麻合法化的總統選票
What Happened
發生了什麼
On Monday, the DEA announced a delay in rescheduling marijuana. The agency said it would hold an administrative hearing on December 2 when it is expected to gather factual evidence and expert opinions to determine the appropriateness of reclassification. The DEA obtained over 40,000 requests for a hearing on the proposed rule making, which seeks to reclassify marijuana from Schedule I to Schedule III.
美國麻醉品管局週一宣佈推遲重新安排大麻的時間表。該機構表示，預計於12月2日舉行行政聽證會，旨在收集事實證據和專家意見，以確定重新分類的適當性。美國麻醉品管局獲得了超過40,000份要求就擬議規則進行聽證會的請求，該規則旨在將大麻從I類藥物重新分類爲III類藥物。
The notice, signed by DEA Administrator Anne Milgram, said that after the agency received notices of intent to participate in the hearing, she would assess them and decide, as reported by Benzinga's Nicolás Jose Rodriguez earlier this week.
美國麻醉品管局局長安妮·米爾格拉姆簽署的通知稱，在機構收到參加聽證會意向通知後，她將對其進行評估並決定，如本週早些時候Benzinga的尼古拉斯·何塞·羅德里格斯報道。
The cannabis market was quick to react to the regulatory news with AdvisorShares Pure US Cannabis ETF (NASDAQ:MSOS) dropping over 10% in early trading on Tuesday, while individual cannabis stocks also saw declines.
大麻市場迅速對監管新聞做出反應，AdvisorShares Pure US Cannabis ETF（納斯達克股票代碼：MSOS）週二早盤交易中下跌超過10％，同時個別大麻股票也出現下跌。
In the meantime, Blumenauer earlier said moving marijuana from Schedule I to Schedule III is "far from sufficient," and that more needs to be done in terms of cannabis reform.
與此同時，布盧門鄂早前表示，將大麻從I類藥物調整爲III類藥物「遠遠不夠」，在大麻改革方面還需要做更多工作。
"While Schedule III ends criminal penalties attached to Schedule I for marijuana offenses, it does not end mandatory minimums specific to marijuana as a controlled substance or other federal criminal penalties for possession, production, or distribution," Blumenauer said earlier this year.
布盧門鄂早些時候表示：「雖然III類藥物結束了與I類藥物有關的大麻違法行爲的刑事處罰，但對於大麻作爲受控物質的強制最低量刑以及持有、生產或分銷的其他聯邦刑事行爲，並沒有結束。」
Read Also: Congressman Earl Blumenauer On NCAA's Removal Of Cannabis From Banned Substances List
閱讀更多：國會議員厄爾·布盧門鄂對NCAA將大麻從禁止物質名單中移除的看法
譯文內容由第三人軟體翻譯。